EZH2 inhibitors in immunotherapy of melanoma

被引：1
|
作者：
Hersey, Peter
Gallagher, Stuart
Tiffen, Jessamy
Shklovskaya, Elena
Wilson, Stephen
Filipp, Fabian
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
基金：
美国国家卫生研究院; 澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
10.1158/1538-7445.AM2017-1676
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1676
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
    Al Emran, Abdullah
    Chatterjee, Aniruddha
    Rodger, Euan J.
    Tiffen, Jessamy C.
    Gallagher, Stuart J.
    Eccles, Michael R.
    Hersey, Peter
    TRENDS IN IMMUNOLOGY, 2019, 40 (04) : 328 - 344
  • [2] EZH2 Inhibitors: The Unpacking Revolution
    Adema, Vera
    Colla, Simona
    CANCER RESEARCH, 2022, 82 (03) : 359 - 361
  • [3] Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas
    Lue, Jennifer Kimberly
    Prabhu, Sathyen A.
    Liu, Yuxuan
    O'Connor, Owen A.
    Amengual, Jennifer E.
    BLOOD, 2016, 128 (22)
  • [4] EZH2 as a mediator of treatment resistance in melanoma
    Tiffen, Jessamy C.
    Gallagher, Stuart J.
    Tseng, Hsin-Yi
    Filipp, Fabian V.
    Fazekas de St Groth, Barbara
    Hersey, Peter
    PIGMENT CELL & MELANOMA RESEARCH, 2016, 29 (05) : 500 - 507
  • [5] Role of the Epigenetic Modifier EZH2 in Melanoma
    Zingg, D.
    Schaefer, S.
    Cheng, P.
    Shakhova, O.
    Chin, L.
    Beermann, F.
    Koseki, H.
    Dummer, R.
    Sommer, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 43 - 44
  • [6] Emerging EZH2 Inhibitors and Their Application in Lymphoma
    Jennifer K. Lue
    Jennifer E. Amengual
    Current Hematologic Malignancy Reports, 2018, 13 : 369 - 382
  • [7] Emerging EZH2 Inhibitors and Their Application in Lymphoma
    Lue, Jennifer K.
    Amengual, Jennifer E.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (05) : 369 - 382
  • [8] The roles of EZH2 in cancer and its inhibitors
    Liu, Yuankai
    Yang, Qiong
    MEDICAL ONCOLOGY, 2023, 40 (06)
  • [9] The roles of EZH2 in cancer and its inhibitors
    Yuankai Liu
    Qiong Yang
    Medical Oncology, 40
  • [10] Enhancer of zeste homolog 2 (EZH2) inhibitors
    Gulati, Nitya
    Beguelin, Wendy
    Giulino-Roth, Lisa
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1574 - 1585
12345